ArticleClinical and experimental medicine2023

Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma.

Ning-Chun Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.